Daiken Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	1,189	1,140	287.07	243.71
Cash & Short-Term Investments	1,189	1,140	287.07	243.71
Cash Growth	-3.25%	297.03%	17.79%	-
Accounts Receivable	109.94	93.5	68.19	53.54
Other Receivables	2.25	0.65	3.33	-
Receivables	112.19	94.15	71.51	53.54
Inventory	326.91	245.71	262.65	178.36
Prepaid Expenses	30.26	31.89	19.39	17.58
Other Current Assets	-	-	92.12	30.71
Total Current Assets	1,658	1,511	732.73	523.9
Property, Plant & Equipment	1.44	3.28	-	-
Other Intangible Assets	5.75	3.74	1.46	1.09
Long-Term Deferred Tax Assets	7.15	11.69	6.53	-
Other Long-Term Assets	12.33	7.62	4.45	5.18
Total Assets	1,685	1,538	745.17	530.17
Accounts Payable	128.06	73.75	53.15	32.4
Accrued Expenses	50.92	63.24	89.3	87.6
Short-Term Debt	-	-	158	33
Current Portion of Long-Term Debt	-	-	69.02	41.63
Current Portion of Leases	0.27	1.82	-	-
Current Income Taxes Payable	30.66	9.37	28.15	19.36
Current Unearned Revenue	8.53	7.26	30.23	21.46
Other Current Liabilities	358.7	74.93	20.45	5.91
Total Current Liabilities	577.14	230.37	448.29	241.37
Long-Term Debt	-	-	49.56	61.37
Long-Term Leases	0.31	0.45	-	-
Total Liabilities	577.63	230.81	497.85	302.74
Common Stock	600.02	600.02	155.4	155.4
Additional Paid-In Capital	437.06	624.06	-	-
Retained Earnings	83.19	83.76	91.92	72.03
Comprehensive Income & Other	-12.85	-0.86	-	-
Shareholders' Equity	1,107	1,307	247.32	227.43
Total Liabilities & Equity	1,685	1,538	745.17	530.17
Total Debt	0.58	2.27	276.58	136
Net Cash (Debt)	1,188	1,137	10.49	107.71
Net Cash Growth	44.46%	10746.37%	-90.26%	-
Net Cash Per Share	19.77	25.90	0.47	6.91
Filing Date Shares Outstanding	60	60	15.54	15.54
Total Common Shares Outstanding	60	60	15.54	15.54
Working Capital	1,081	1,281	284.44	282.53
Book Value Per Share	18.46	21.78	15.92	14.64
Tangible Book Value	1,102	1,303	245.86	226.34
Tangible Book Value Per Share	18.36	21.72	15.82	14.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.